Microglia in ischemic brain injury.
Microglia are resident CNS immune cells that are active sensors in healthy brain and versatile effectors under pathological conditions. Cerebral ischemia induces a robust neuroinflammatory response that includes marked changes in the gene-expression profile and phenotype of a variety of endogenous CNS cell types (astrocytes, neurons and microglia), as well as an influx of leukocytic cells (neutrophils, macrophages and T-cells) from the periphery. Many molecules and conditions can trigger a transformation of surveying microglia to microglia of an alerted or reactive state. Here we review recent developments in the literature that relate to microglial activation in the experimental setting of in vitro and in vivo ischemia. We also present new data from our own laboratory demonstrating the direct effects of in vitro ischemic conditions on the microglial phenotype and genomic profile. In particular, we focus on the role of specific molecular signaling systems, such as hypoxia inducible factor-1 and Toll-like receptor-4, in regulating the microglial response in this setting. We then review histological and novel radiological data that confirm a key role for microglial activation in the setting of ischemic stroke in humans. We also discuss recent progress in the pharmacologic and molecular targeting of microglia in acute ischemic stroke. Finally, we explore how recent studies on ischemic preconditioning have increased interest in pre-emptively targeting microglial activation in order to reduce stroke severity.
Weinstein
Jonathan R
JR
Department of Neurology, School of Medicine, University of Washington, Seattle, Washington 98195-6465, USA Tel.: +1 206 221 5362 jweinste@u.washington.edu.
Koerner
Ines P
IP
Möller
Thomas
T
J Cereb Blood Flow Metab. 2007 Dec;27(12):1975-86
17457364
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
J Neuroinflammation. 2004 Jun 30;1(1):9
15285793
Trends Neurosci. 1999 Sep;22(9):391-7
10441299
J Immunol. 2009 Mar 1;182(5):3155-64
19234213
Biochem Biophys Res Commun. 2008 Jun 27;371(2):283-8
18435916
Nat Rev Immunol. 2005 Sep;5(9):712-21
16110315
Curr Opin Neurol. 2001 Jun;14(3):349-53
11371759
J Neurol Sci. 1998 Nov 26;161(1):16-22
9879676
Exp Neurol. 2005 Dec;196(2):290-7
16153641
Stroke. 2004 Mar;35(3):616-21
14963288
J Immunol. 1995 May 1;154(9):4309-21
7722289
Can J Physiol Pharmacol. 2006 Jan;84(1):49-59
16845890
Glia. 2008 Jan 1;56(1):16-26
17910052
Antioxid Redox Signal. 2006 May-Jun;8(5-6):911-8
16771681
Exp Neurol. 2008 Sep;213(1):114-21
18586243
Lancet. 2003 Jan 11;361(9352):107-16
12531577
Nat Neurosci. 2007 Nov;10(11):1387-94
17965659
Science. 2000 Dec 1;290(5497):1768-71
11099416
Mol Cell Neurosci. 2004 Feb;25(2):312-22
15019947
Stroke. 2004 Jul;35(7):1659-64
15155970
Nat Rev Neurosci. 2006 Jun;7(6):437-48
16715053
J Immunol. 2009 Jun 15;182(12):7603-12
19494284
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13496-500
10557349
Acta Neuropathol. 1998 Aug;96(2):172-8
9705133
Acta Neuropathol. 1996 Sep;92(3):281-7
8870830
Lancet. 2003 Sep 27;362(9389):1028-37
14522533
J Pharmacol Sci. 2004 Feb;94(2):203-6
14978360
J Pathol. 2002 Feb;196(2):204-12
11793372
JAMA. 2000 Dec 13;284(22):2901-6
11147987
J Cereb Blood Flow Metab. 2007 Oct;27(10):1663-74
17327883
Neurochem Int. 2006 Jul;49(2):145-53
16759751
J Cereb Blood Flow Metab. 1998 May;18(5):521-30
9591844
Trends Neurosci. 1996 Aug;19(8):312-8
8843599
Methods Enzymol. 2007;435:221-45
17998057
J Neuroimmune Pharmacol. 2006 Jun;1(2):127-37
18040779
Stroke. 1997 Feb;28(2):382-6
9040694
Glia. 2002 Nov;40(2):133-9
12379901
Stroke. 2006 Jul;37(7):1749-53
16763188
Glia. 2002 Nov;40(2):140-55
12379902
Heart. 2003 Jul;89(7):767-72
12807853
J Neurosci. 2009 Aug 5;29(31):9839-49
19657036
Brain Res. 2009 Mar 25;1262:100-8
19401158
Stroke. 2007 Jan;38(1):131-7
17122417
J Neurochem. 2005 Mar;92(6):1363-76
15748155
Eur J Neurosci. 1998 Feb;10(2):680-8
9749729
Brain Res Mol Brain Res. 2002 Oct 30;107(1):9-16
12414118
J Cereb Blood Flow Metab. 2005 Dec;25(12):1634-44
15931160
J Neurosci. 2008 Mar 5;28(10):2320-31
18322079
Neurochem Res. 2009 Mar;34(3):445-52
18686031
J Immunol. 2007 Jun 15;178(12):7516-9
17548584
Stroke. 2004 Nov;35(11):2576-81
15375302
Nat Neurosci. 2006 Jul;9(7):917-24
16732273
Mol Biol Cell. 2007 Jan;18(1):14-23
17065555
Glia. 1998 Jan;22(1):72-85
9436789
J Clin Invest. 2005 Jul;115(7):1806-15
16007254
J Immunol. 2003 Dec 15;171(12):6549-55
14662856
J Cereb Blood Flow Metab. 2010 Jan;30(1):230-41
19794397
Cell Metab. 2006 Nov;4(5):349-62
17055784
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):659-60
15026523
J Neurosci. 1997 Jan 15;17(2):615-24
8987784
Trends Pharmacol Sci. 2003 Aug;24(8):402-8
12915049
Stroke. 2007 Feb;38(2 Suppl):680-5
17261715
Future Neurol. 2009;4(2):201-208
19885374
J Cereb Blood Flow Metab. 2004 Nov;24(11):1288-304
15545925
Glia. 2005 Jun;50(4):340-50
15846799
Stroke. 1999 Dec;30(12):2752-8
10583007
Circulation. 2007 Mar 27;115(12):1599-608
17372179
NMR Biomed. 2004 Jun;17(4):163-9
15229929
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
16199517
J Neurochem. 2008 Jul;106(1):442-54
18419765
Acta Neuropathol. 1978 Sep 15;43(3):259-62
279210
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10873-8
9380727
Am J Pathol. 2002 Jun;160(6):2231-44
12057925
J Neuroimmunol. 2007 Oct;190(1-2):101-11
17884182
J Cereb Blood Flow Metab. 2008 May;28(5):927-38
18000511
J Pharmacol Sci. 2005 Feb;97(2):289-93
15684564
J Immunol. 2008 Apr 1;180(7):4697-705
18354193
Stroke. 2009 May;40(5):1834-41
19286601
Exp Neurol. 2003 Sep;183(1):25-33
12957485
Glia. 2002 Nov;40(2):206-17
12379908
Cell. 2003 Mar 7;112(5):645-57
12628185
J Cereb Blood Flow Metab. 2007 Dec;27(12):1941-53
17440490
Curr Opin Pharmacol. 2008 Feb;8(1):8-13
17974478
Neurology. 2007 Oct 2;69(14):1404-10
17909152
Stroke. 2000 Jul;31(7):1735-43
10884481
Science. 2009 Mar 27;323(5922):1722-5
19264983
J Cereb Blood Flow Metab. 2009 Jun;29(6):1216-25
19352400
Neurology. 1986 Jun;36(6):844-7
3458032
Nat Neurosci. 2005 Jun;8(6):752-8
15895084
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
11309499
J Cereb Blood Flow Metab. 2007 Mar;27(3):488-500
16820801
J Neuroimmune Pharmacol. 2009 Dec;4(4):399-418
19655259
J Neurochem. 2005 Nov;95(4):1177-87
16271051
Curr Opin Anaesthesiol. 2006 Oct;19(5):481-6
16960478
J Neurosci. 2008 Feb 27;28(9):2221-30
18305255
J Biol Chem. 2001 Jul 13;276(28):25946-52
11340076
Glia. 2005 Apr 1;50(1):48-55
15625717
Brain. 2004 Jul;127(Pt 7):1670-7
15128622
Stroke. 2009 May;40(5):1849-57
19265055
Glia. 2009 Jun;57(8):835-49
19053043
J Comp Neurol. 1993 Jan 1;327(1):123-32
8432904
Brain Res. 2002 Apr 5;932(1-2):110-9
11911867
Trends Neurosci. 2006 Feb;29(2):68-74
16406093
Biochem Biophys Res Commun. 2007 Feb 9;353(2):509-14
17188246
J Neurochem. 2009 Apr;109(1):287-94
19200341
Stroke. 2001 Jan;32(1):206-11
11136938
Glia. 2006 Jun;53(8):809-16
16541436
J Neurosci. 2007 Mar 7;27(10):2596-605
17344397
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15769-74
9861045
Neurology. 2000 Oct 10;55(7):1052-4
11061271
Mol Cell Neurosci. 2006 Jan;31(1):149-60
16297637
Neurosci Lett. 2001 Jan 26;298(1):5-8
11154822
Science. 2005 May 27;308(5726):1314-8
15831717
Neurosci Lett. 2008 Jan 31;431(2):155-60
18164813
J Neurosurg. 2005 Jun;102(6):1076-84
16028767
Stroke. 2007 Jan;38(1):146-52
17122429
Magn Reson Med. 2001 Nov;46(5):1018-22
11675656
Neurosci Lett. 2009 Oct 16;464(1):29-33
19679164
Folia Neuropathol. 1996;34(1):17-24
8855083